Chapter 97: The Public Correction
Sterling's statement used one hundred eighty-three words to correct nothing.
It said the company respected all scientific contributors, maintained productive relationships with its licensors, and remained confident in the Northstar transaction. It described the silver crown as a beloved Sterling tradition.
It did not name the inventor.
It did not say the license was suspended.
It did not identify who owned the crown.
The statement appeared fifty-nine minutes after our deadline.
Rhea read it once. "They chose ambiguity."
The Trust's public correction was already prepared, but the trustees reviewed every line again. We would not publish Nathan's certifications, Conrad's compensation offer, confidential transaction schedules, or any protected safety material.
The correction contained only three facts.
First: Helena Research Trust's relevant AURORA-9 license to Sterling remained suspended.
Second: an independent determination identified Dr. Evelyn Sterling as the platform's principal inventor and denied Celeste Sterling co-inventor status.
Third: the silver crown belonged to Helena Research Trust and was held by Sterling under a conditional display loan.
The provenance certificate and public determination were linked. The suspension notice appeared with its effective date and scope. Participant names, research parameters, and private correspondence did not appear.
"Do you want a statement in your own voice?" Rhea asked.
"No."
The facts did not need my anger to become clearer.
At ten, the trustees released the correction through the Trust's public archive. I watched the page load from Mercer Nova's external conference room. Julian stood on the other side of the table, reading the same three paragraphs as everyone else.
He did not issue a Mercer statement.
Within minutes, reporters asked whether the Trust intended to license AURORA-9 to Northstar or Mercer. The trustees answered that no new license had been granted and no transaction decision was being announced.
Sterling called the correction selective.
It did not call it false.
Its lawyers requested that the Trust remove the statement until Northstar completed review. The trustees refused. Each posted fact came from an authenticated record within the Trust's own authority to describe. The Trust did not need Sterling's permission to state the status of its license, its property, or a completed attribution determination.
Celeste posted the centennial photograph again with the caption SOME LEGACIES CANNOT BE ERASED. The image showed her wearing an object the linked certificate said she did not own.
Northstar's legal team requested a delay in all public promotion using the crown. Its business team asked Sterling for an amended rights schedule by close of day.
Nathan responded that the Trust was interfering with a lawful merger.
Rhea replied publicly only to the extent necessary: exercising ownership and license rights was not interference with someone else's property.
By noon, the prospectus link carried a notice that supplemental information was under review. The seven-billion-dollar valuation remained visible. The signing date remained listed.
Nothing had ended.
But investors could now read the three omitted facts without entering a sealed room.
Employees could read them too.
Messages reached my professional inbox from Sterling scientists who wanted to know whether suspended licensing meant their safety work had to stop. The Trust posted a clarification that necessary preservation and approved safety maintenance could continue under existing controls. It did not authorize new use or make promises about jobs.
It also directed operational questions to Sterling's board rather than to me. I could explain the license boundary. I could not pretend to manage a company that had not given me a seat or a vote.
That distinction mattered. A correction should not become another vague threat.
Late in the afternoon, the fictional Bellhaven Exchange requested information from Sterling and Northstar about the conflicting rights statements. Trading continued while the review began.
Conrad released no personal response.
The board announced another emergency session.
At four thirty-seven, the exchange asked both companies whether an orderly market could continue before the prospectus was corrected.
The question did not belong to me.
For forty-eight hours, Sterling's directors had been allowed to answer first.
Now the market had heard what they refused to say.